Delivery Order SPE2DB22D2007-SPE2DB26FH6NS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,595.18 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pen injections on August 14, 2025. This non-competitive, firm fixed-price delivery order is scheduled for completion by August 15, 2025, with performance occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pen injections on June 4, 2025, with an ultimate completion date of June 5, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively to AmerisourceBergen's Corporate Office division located in Conshohocken, Pennsylvania. The contract represents a single transaction for pharmaceutical supply under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $2,026.98. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The contract is scheduled for completion by October 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injections, valued at $1,181.90, with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a $11,940.80 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $2,852.85 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Trulicity 3 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,628.68 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections with an ultimate completion date of August 19, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to a qualified vendor. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,308.30 for Trulicity 3 mg/0.5 mL pens on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a pharmaceutical supply transaction under AmerisourceBergen's broader federal contract portfolio. The product will be performed at the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,263.40 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trulicity 3 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract represents a single delivery order with a completion deadline of September 16, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was competed among qualified vendors capable...
- The Defense Logistics Agency awarded a $4,973.15 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 3 mg/0.5 mL pen auto-injectors. This contract, designated as a firm fixed price delivery order with an ultimate completion date of September 9, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was made through open competition with no set-aside designation, demonstrating AmerisourceBergen's...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB26FH6NSDelivery Order
The Defense Logistics Agency awarded a $23,513.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pen injections on October 28, 2025, with an ultimate completion date of October 29, 2025. This competitively awarded contract, which carries no set-aside designation, represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, though the ultimate end-use is for federal military and healthcare system beneficiaries. This delivery order is issued under AmerisourceBergen's comprehensive pharmaceutical prime vendor IDC valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated consistent capability in meeting federal procurement requirements through open competition across multiple therapeutic domains, including diabetes medications, neurological treatments, and specialized medical supplies for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.5k | 10/28/25 |